Login / Signup

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma.

Enrico N De ToniJulia MayerleBettina OehrleMax SeidenstickerLorenza RimassaAlexander PhilippDaniel RoesslerNajib Ben Khaled
Published in: Alimentary pharmacology & therapeutics (2024)
Keyphrases
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label